The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD
June 28th 2022A noninterventional study found that chart-based assessments of visual function had adequate repeatability but were limited in discriminating between no age-related macular degeneration (AMD) and intermediate AMD.
Read More
Analysis Finds Ranibizumab PDS Cost-Saving in Long-term Scenarios
June 22nd 2022A recent study found that the ranibizumab port delivery system (PDS) has cost-saving potential compared with regular ranibizumab or aflibercept injections for age-related macular degeneration if used in the long term.
Read More
Dr Steven Yeh Discusses Future of Suprachoroidal Drug Delivery
May 25th 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, talks about what he sees in the future of suprachoroidal administration and other unmet needs in ophthalmology.
Read More
Dr Steven Yeh Explains Xipere Follow-up Findings, Learning Curves for Clinicians
May 2nd 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, discusses the length of Xipere's treatment benefits and potential learning curves regarding its suprachoroidal delivery mechanism.
Read More
RNA Sequencing Identifies Novel, Specific Biomarkers in Pterygia
May 1st 2022While risk factors for pterygia are well-known, the underlying disease mechanisms have not been fully clarified in past studies. A new analysis using RNA sequencing pinpointed ptergyia-specific biomarkers and potential therapeutic targets.
Read More
Patients may have unrealistic expectations of how a new treatment or procedure may help them, and the conversation between the patient and physician is crucial for setting expectations, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Read More
Dr Shoaib Ugradar Addresses Presenting Patients With Treatment Options and Informing Them About AEs
April 11th 2022While teprotumumab, a new FDA-approved therapy for thyroid eye disease (TED), has its adverse events, the other options to treat TED can have severe consequences, said Shoaib Ugradar, MD, UCLA Stein Eye Center Santa Monica.
Read More
Dr Robert Fante Explains Managing Patient Expectations During Treatment or Surgery
March 28th 2022It’s important that patients understand the likely outcomes, problems that can occur along the way, and the risks of a treatment or procedure, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Read More
Key Takeaways on Optimizing Glaucoma Management
Closing out their discussion on glaucoma management, experts share practical advice for care providers and payers alike.
Read More